Rheumatoid Arthritis Clinical Trials in Los Angeles

Showing 2041-2060 of 3,190 trials

A Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS)

NCT00790582

This is a Phase II screening study of lithium carbonate in ALS. The purpose of this study is to find out if lithium carbonate is safe to be used in people with ALS and if it can slow the progression of the disease. Since there is no placebo in this study, all patients will be taking lithium carbonate.

Amyotrophic Lateral Sclerosis

Forbes Norris MDA/ALS Research Center109 participantsStarted May 2008

Scottsdale, Arizona, United States • Los Angeles, California, United States • Orange, California, United States +7 more locations

TERMINATEDPhase 2< 1 mile

Field Administration of Stroke Therapy-Blood Pressure Lowering

NCT01811693

This is an open, pilot, dose-escalation study of glyceryl trinitrate (GTN, Nitroglycerin) administered by paramedics in the field within 2 hours of symptom onset to 45 severely hypertensive stroke patients. The primary objective of the study is to evaluate the feasibility, safety, and physiologic efficacy of field-initiated glyceryl trinitrate in achieving modest reduction of blood pressure. Patients with acute stroke will be identified in the field by paramedics who have received training in basic and advanced cardiac life support, stroke recognition, and specific procedures relevant to the proposed study. Physician-investigators will obtain informed consent for each subject for study entry after cellular phone contact with paramedics. Paramedics will initiate antihypertensive treatment by applying transdermal GTN patch in the first two dose-tiers, and administering a single sublingual GTN metered spray followed by application of the transdermal system in the last dose tier. The sites involved in the study will be emergency medical services rescue ambulances and 8 receiving Stroke Center hospitals in Orange County, California, USA.

Intracerebral HemorrhageIschemic Stroke

University of California, Los Angeles4 participantsStarted Apr 2013

Los Alamitos, California, United States • Los Angeles, California, United States

A Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Field Administration of Stroke Therapy-Blood Pressure Lowering

Rheumatoid Arthritis Trials in Other Cities

Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases

Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors

Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy

The NanoStrand Clinical Study

Safety and Biomarker Study of EPI-589 in Participants With Amyotrophic Lateral Sclerosis (ALS)

Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes

Study of Intravitreal REGN2176-3 in Participants With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)

Study of NGM621 in Participants With Geographic Atrophy

Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma

Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study

BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease

Study of T-PRED(TM) Compared to Pred Forte(R) II

TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)

MLD10 in the Prevention of Migraine in Adults

Comparative Study of Two Marketed Spherical Soft Contact Lenses

Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas

Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer

An Evidence Based Delivery Model of Care for Newly Implanted Adult CI Recipients

Other Conditions in Los Angeles